Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Interferon-induced transmembrane protein 3 in hepatocellular carcinoma patients.

BMC cancer - 23 Jun 2023

Bondok Rania M, Barakat Lamiaa A, Elsergany Alyaa R, Mahsoub Nancy, Ghattas Maivel H

Abstract excerpt

OBJECTIVE: The study aimed to investigate the over expression of IFITM3 in hepatocellular carcinoma Egyptian patients. BACKGROUND: Hepatocellular carcinoma (HCC) continues to be a serious disease burden. Interferon Induced Transmembrane protein 3 (IFITM3) is a protein that encoded in humans by the IFITM3 gene. It plays a critical role in the immune system's defense, responsible for a large portion of the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Hepatocellular
Share to Hepacivirus
Share to Hepatitis C

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Interferons

Share to Liver Neoplasms

Share to Membrane Proteins

Share to Polymorphism, Single Nucleotide

Share to RNA-Binding Proteins

Source

Open in PubMed Open full text

Identifiers

PMID: 37353775
DOI: 10.1186/s12885-023-11071-2
PMCID: PMC10290370

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Interferon-induced transmembrane protein 3 in hepatocellular carcinoma patients.PMID 37353775Read ↗

Relationship between interferon-induced transmembrane protein 3 and matrix metalloproteinase-9 gene polymorphisms in patients with hepatocellular carcinoma.Semantic proximity Read ↗

Interferon induced IFIT family genes in host antiviral defense.Semantic proximity Read ↗

Molecular Characterization, Expression and Functional Analysis of Yak IFITM3 GeneSemantic proximity Read ↗

The Interferon-induced transmembrane protein 3 gene (IFITM3) rs12252 C variant is associated with COVID-19.Semantic proximity Read ↗

Interferon-Induced Transmembrane Protein-3 Rs12252-G Variant Increases COVID-19 Mortality Potential in Egyptian Population.Semantic proximity Read ↗

Study of Toll-like Receptor 3 Gene Polymorphism as a Novel Risk Factor for HCV-related Hepatocellular Carcinoma in Egypt.Semantic proximity Read ↗

The emerging roles of IFIT3 in antiviral innate immunity and cellular biologySemantic proximity Read ↗

Interferon-Induced Transmembrane Protein 3 Shapes an Inflamed Tumor Microenvironment and Identifies Immuno-Hot TumorsSemantic proximity Read ↗

Interferon-induced transmembrane protein-3 genetic variant rs12252 is associated with COVID-19 mortality.Semantic proximity Read ↗

IFIT3 Is Increased in Serum from Patients with Chronic Hepatitis B Virus (HBV) Infection and Promotes the Anti-HBV Effect of Interferon Alpha via JAK-STAT2 In VitroSemantic proximity Read ↗

Chitinase 3-like-1, Tolloid-like protein 1, and intergenic gene polymorphisms are predictors for hepatocellular carcinoma development after hepatitis C virus eradication by direct-acting antivirals.Semantic proximity Read ↗

Impact of interferon-induced transmembrane protein 3 gene rs12252 polymorphism on COVID-19 mortality.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.